CureVac NV sues BioNTech for IP infringement
German mRNA vaccine developer CureVac, whose COVID-19 vaccine was not effective, on Monday sued BioNTech/Pfizer for infringement of four patents.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1125 entries already.
Entries by Thomas Gabrielczyk
French Ipsen falls after Epizyme take-over announcement
/in News/by Thomas GabrielczykShares of French drugmaker Ipsen fell by 4.4% at Euronext Paris after the company announced to take over US cancer specialist Epizyme Inc. for $247m.
TWB announces winners in industrial biotech start-up contest
/in News/by Thomas GabrielczykAt the end of the TWB Start-up day, which was attended by more than 200 biotech professionals, two industrial biotechnology companies were awarded prizes worth 50,000.
BIONTech breaks ground for manufacturing site in Rwanda
/in News/by Thomas GabrielczykBioNTech SE has announced it is going to ship the first containers for mRNA malaria vaccine production from this years end toKigall.
Cannabis players Canify AS and Bavaria Weed merge to form Canify AG
/in News/by Thomas GabrielczykIn an effort to become a major player in Europes growing pharmaceutical-grade cannabis market, Danish Canify AS and Bavaria Weed GmbH merge to form Canify AG.
French ImCheck get´s a USD103m check by Pfizer and a pack of VCs
/in News/by Thomas GabrielczykImCheck Therapeutics located in Marseille, France, announced today the close of a EUR 96 million (USD 103 million) financing, co-led by Earlybird and Andera Partners. Kurma Partners, Eurazeo, Gimv, Pfizer, […]
$50m for London CHARM Therapeutics for deep minded folding expertise
/in News/by Thomas GabrielczykCHARM Therapeutics launches with a $50 million Series A financing to transform structure-based drug discovery using its proprietary DragonFold AI technology.
Biotalys first proteinbased biocontrol shows up in vineyards
/in News/by Thomas GabrielczykBased on data from the latest trials in grapes across vineyards in diverse climates throughout California and New York, Biotalys’ biocontrol product Evoca provided superior preventative control of Botrytis bunch […]
Andera Partners co-leads $118m Series B of Mineralys thx (USA)
/in News/by Thomas GabrielczykAndera Partners, Paris based European private equity player, announced on Wednesday that, together with RA Capital Management, it is leading an oversubscribed and up-sized $118m Series B financing for Mineralys […]
From waste to sugar – demonstration plant opens in Wales
/in News/by Thomas GabrielczykThe South Wales-based demonstration plant "VAMOS" that generates industrial biotechnology sugars and other recycled material streams from the paper and card in mixed household waste has come online these days. […]